Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer
Early Phase 1
Completed
- Conditions
- Pancreatic Adenocarcinoma Locally AdvancedPancreatic Adenocarcinoma MetastaticPancreatic Adenocarcinoma Resectable
- Interventions
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2020-09-04
- Lead Sponsor
- Jean-Luc Van Laethem
- Target Recruit Count
- 23
- Registration Number
- NCT01715142
- Locations
- π§πͺ
Antwerp University Hospital (UZA), Edegem, Antwerpen, Belgium
π§πͺErasme University Hospital (ULB), Brussels, Belgium
Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer
Early Phase 1
- Conditions
- Pancreatic Adenocarcinoma Resectable
- Interventions
- First Posted Date
- 2012-10-24
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- Jean-Luc Van Laethem
- Target Recruit Count
- 21
- Registration Number
- NCT01713218
- Locations
- π§πͺ
Erasme University Hospital (ULB), Brussels, Belgium
π§πͺAntwerp University Hospital (UZA), Edegem, Antwerpen, Belgium
Β© Copyright 2025. All Rights Reserved by MedPath